Eko honored for achievements in AI-powered solutions to improve cardiac care BERKELEY, Calif.–(BUSINESS WIRE)–Eko today announced that it has been named to CB Insights’ fourth annual AI 100 ranking, showcasing the 100 most promising private artificial intelligence companies in the world. “Eko has […]
Tag: Eko
FDA Clears Eko’s AFib and Heart Murmur Detection Algorithms, Making It the First AI-Powered Stethoscope to Screen for Serious Heart Conditions
Eko’s algorithms alert clinicians to the presence of heart murmurs and atrial fibrillation (AFib) during the physical exam, converting the classic stethoscope into a powerful early detection tool SAN FRANCISCO–(BUSINESS WIRE)–Eko, a digital health company applying artificial intelligence (AI) in […]
FDA Grants ‘Breakthrough’ Designation to Eko’s ECG-based Low Ejection Fraction Screening Algorithm, Designed to Improve Detection of Heart Failure
Developed in collaboration with Mayo Clinic, the algorithm would help healthcare providers detect heart failure during a standard physical exam San Francisco, CA, Dec. 18, 2019 (GLOBE NEWSWIRE) — Eko, a digital health company applying artificial intelligence (AI) in the fight […]
Eko Makes Stethoscopes Even Smarter with the Redesigned CORE
The redesigned Eko CORE boasts active noise cancellation, sleeker design, and powerful software to allow medical professionals to more effectively screen for heart disease San Francisco, CA, Nov. 25, 2019 (GLOBE NEWSWIRE) — Eko, a digital health company with an AI-powered […]
AI-Powered Digital Health Company Eko Closes $20 Million Series B to Continue the Fight Against Heart Disease
Led by ARTIS Ventures, Funding will Drive Further Research and Commercialization of Eko’s Machine Learning Platform San Francisco, CA, Sept. 25, 2019 (GLOBE NEWSWIRE) — Eko, a Silicon Valley-based digital health company building machine learning tools to fight heart disease, today […]
Eko Launches ‘Eko Home,’ a Cardiac Remote Monitoring Application Enabling Powerful Drug-Data Combinations to Enhance Clinical Studies and Pharmaceutical Trials
San Francisco, July 25, 2019 (GLOBE NEWSWIRE) — Eko, a Silicon Valley-based digital health company applying machine learning in the fight against heart disease, today announced Eko Home, a first-of-its-kind service that enables precise remote monitoring of cardiac function using ECG […]
Eko Unveils Algorithm to Assist in the Detection of Aortic Stenosis, a Valvular Heart Disease Affecting Over 3 Million People in the U.S.
Berkeley, June 28, 2019 (GLOBE NEWSWIRE) — Eko, a Berkeley-based digital health company applying artificial intelligence and machine learning in the fight against heart disease, unveiled an investigational Aortic Stenosis (AS) detection algorithm at the American Society of Echocardiography (ASE) 2019 Scientific Sessions […]
Northwestern Medicine and Eko Partner to Improve Valvular Heart Disease Screening Using Machine Learning Algorithms
CHICAGO, March 7, 2019 /PRNewswire/ — Northwestern Medicine Bluhm Cardiovascular Institute is pioneering the use of artificial intelligence (AI) for cardiac screening in a new study of Eko’s cardiac monitoring platform. The study aims to demonstrate that Eko’s digital stethoscopes and AI algorithms can interpret heart […]
Eko Collaborates with Mayo Clinic on a Machine Learning-Based Algorithm to Help Physicians Better Screen for Potentially Dangerous Heart Diseases
Berkeley, CA, Oct. 25, 2018 (GLOBE NEWSWIRE) — Eko, creators of a heart and lung monitoring platform that combines non-invasive cardiac sensors with machine learning, has announced a collaboration with Mayo Clinic to develop a data-driven technology – using machine learning […]